Working… Menu
Trial record 2 of 5 for:    multitaa

Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02494167
Recruitment Status : Recruiting
First Posted : July 10, 2015
Last Update Posted : June 25, 2019
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
American Society for Blood and Marrow Transplantation (ASBMT)
Cancer Prevention Research Institute of Texas
Information provided by (Responsible Party):
Premal Lulla, Baylor College of Medicine

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2020
Estimated Study Completion Date : February 2025